Since the beginning of the epidemic in the early 1980s, approximately 42.3 million people have died from AIDS-related illnesses worldwide. In 2024 alone, around 630,000 people died from these causes, a number that, while still devastating, represents a 70% drop from the epidemic’s deadliest year.
The Global Death Toll Over Time
AIDS-related deaths peaked in 2004 at roughly 2.1 million in a single year. At that point, antiretroviral therapy existed but had not yet reached most of the people who needed it, particularly in low-income countries. The introduction of large-scale treatment programs began turning the tide. By 2010, annual deaths had fallen to about 1.4 million. By 2024, that number dropped to 630,000.
That trajectory matters because it shows that most AIDS deaths are now preventable. The virus has not become less dangerous on its own. What changed is access to treatment. Antiretroviral therapy suppresses HIV to the point where a person’s immune system can recover and function normally, preventing the opportunistic infections that actually kill people with AIDS. When someone starts treatment early and stays on it, their life expectancy approaches that of someone without HIV.
Where Deaths Are Concentrated
Sub-Saharan Africa has borne the overwhelming majority of the epidemic’s toll and continues to do so. About 25.6 million people in the WHO African region are living with HIV today, making it home to roughly two-thirds of all people with the virus worldwide. In 2022, approximately 380,000 people in the region died from AIDS-related illness, accounting for well over half of global deaths that year.
Within the continent, the burden is uneven. East and Southern Africa has about 20.8 million people living with HIV, while West and Central Africa has 4.8 million. The reasons for this concentration are complex, involving decades of limited healthcare infrastructure, poverty, stigma that discourages testing, and supply-chain challenges that interrupt treatment access. Countries like South Africa, Mozambique, and Nigeria carry some of the largest absolute numbers.
Children and AIDS
An estimated 75,000 children under 15 died from HIV-related causes in 2024. That figure is especially troubling because preventing mother-to-child transmission is one of the most straightforward interventions in HIV care. When a pregnant woman with HIV receives proper treatment, the chance of passing the virus to her baby drops below 1%. Yet an estimated 1.3 million children in the African region alone were living with HIV as of 2022, most of whom acquired the virus during pregnancy, birth, or breastfeeding.
Children with HIV face particular challenges. Pediatric formulations of antiretroviral drugs have historically been harder to produce and distribute, and diagnosing infants requires specialized testing that many clinics in high-burden areas lack. These gaps mean children are more likely to go undiagnosed and untreated, which is why their mortality rate remains disproportionately high relative to adults.
Tuberculosis: The Leading Killer
Not everyone who dies from an AIDS-related illness dies from HIV itself. The virus destroys immune cells, leaving the body vulnerable to infections it would normally fight off. Tuberculosis is the single biggest killer of people with HIV. In 2024, about 150,000 people died from HIV-associated TB, making it responsible for roughly one in four AIDS-related deaths globally.
This overlap is especially common in sub-Saharan Africa and parts of Southeast Asia, where both diseases circulate widely. TB is curable with a course of antibiotics, and people with HIV can take preventive TB therapy to reduce their risk. But in practice, many people are diagnosed with one infection and not screened for the other, or they start treatment too late. Closing that gap is one of the most direct ways to reduce the remaining death toll.
How 630,000 Deaths Compare to the Goal
The international target, set by UNAIDS in alignment with the United Nations Sustainable Development Goals, is to reduce AIDS-related deaths by 90% from the 2010 level by 2030. Since about 1.4 million people died in 2010, that target means bringing annual deaths below roughly 140,000. The current figure of 630,000 is less than halfway to that goal with limited time remaining.
The decline in deaths has slowed in recent years compared to the rapid progress seen between 2005 and 2015. The people still dying are largely those the healthcare system has failed to reach: individuals who don’t know their status, people who were diagnosed late, those who started treatment but couldn’t maintain it due to cost or stigma, and populations in conflict zones or areas with weak health infrastructure. Reaching them requires different strategies than the ones that drove the earlier gains, which is why progress has become harder.
What Drives the Remaining Deaths
The 630,000 people who died in 2024 were not an inevitable consequence of the virus. Nearly all of these deaths occurred in people who were either undiagnosed, diagnosed but not on treatment, or on treatment that wasn’t working effectively. Globally, about 86% of people living with HIV know their status, and of those, roughly 89% are on treatment. But those seemingly high percentages still leave millions without adequate care, and the gaps are largest in the regions with the highest burden.
Stigma remains one of the most persistent barriers. In many communities, an HIV diagnosis still carries social consequences severe enough that people avoid testing altogether. Criminalization of sex work, drug use, and same-sex relationships in dozens of countries pushes the populations most vulnerable to HIV further from healthcare. Until those structural barriers are addressed, the death toll will remain far higher than the science alone would suggest it needs to be.